List view / Grid view
25 August 2015 | By Victoria White
Novo Nordisk has announced headline results from the final Phase 3a trial with liraglutide as adjunct therapy to insulin for people with type 1 diabetes...
20 July 2015 | By Victoria White
The FDA has approved Novo Nordisk’s FlexPro PenMate, designed for users of Norditropin FlexPro pens who dislike needles and prefer them to be hidden...
13 July 2015 | By Victoria White
Novo Nordisk has released headline results from SUSTAIN1, the first Phase 3a trial for semaglutide, a GLP-1 analogue administered once-weekly...
2 July 2015 | By Victoria White
Novo Nordisk has decided to cease distribution of its once-daily basal insulin Tresiba (insulin degludec) in Germany...
29 June 2015 | By Victoria White
The CHMP has issued a positive opinion for the expanded use of Novo Nordisk’s Levemir (insulin detemir) in children with diabetes as young as one year old...
24 June 2015 | By Victoria White
Novo Nordisk announced the interim data from an extension trial of Novoeight at the International Society on Thrombosis and Haemostasis 2015 congress...
8 June 2015 | By Victoria White
Phase 3b findings show adults with T2D treated with Xultophy demonstrate statistically significant reduction in HbA1c and a lower rate of hypoglycaemia...
8 June 2015 | By Victoria White
New findings showed that adults with type 2 diabetes treated with Victoza experienced improvements in blood glucose control while fasting during Ramadan...
27 May 2015 | By Victoria White
The SCALE Obesity and Prediabetes trial met its primary endpoint, demonstrating that ongoing treatment with Saxenda delayed the onset of type 2 diabetes...
26 May 2015 | By Victoria White
The South Asian Health Foundation (SAHF) has been named ‘Diabetes Team of the Year’ at the prestigious 2015 BMJ Awards...
11 May 2015 | By Victoria White
Data from a post-hoc analysis of a Phase 3a trial demonstrates the weight-loss-dependent and independent effects of liraglutide 3 mg...
14 April 2015 | By Victoria White
The Changing Diabetes in Children programme, a scheme that has provided free insulin to 13,000 children since 2009, has been extended by three years.
13 April 2015 | By Victoria White
Novo Nordisk has opened a manufacturing facility in the Kaluga region of Russia for formulation and filling of modern insulin for the treatment of diabetes...
27 March 2015 | By Victoria White
Novo Nordisk has announced that it has decided to resubmit New Drug Applications of Tresiba and Ryzodeg to the FDA within the month.
11 March 2015 | By Novo Nordisk
Latest data announced at Diabetes UK reinforces the long-term efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes...
